Cargando…

YKL‐40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma

Detalles Bibliográficos
Autores principales:	James, Anna J., Nordlund, Björn, Konradsen, Jon R., Ebersjö, Christina, Dahlén, Sven‐Erik, Berggren Broström, Eva, Hedlin, Gunilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Regular Articles & Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891389/ https://www.ncbi.nlm.nih.gov/pubmed/32772428 http://dx.doi.org/10.1111/apa.15525

Ejemplares similares

A Novel Association between YKL-40, a Marker of Structural Lung Disease, and Short Telomere Length in 10-Year-Old Children with Bronchopulmonary Dysplasia
por: Henckel, Ewa, et al.
Publicado: (2021)

The cytokine interleukin-26 as a biomarker in pediatric asthma
por: Konradsen, Jon R., et al.
Publicado: (2016)

Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma
por: Um-Bergström, Petra, et al.
Publicado: (2019)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia
por: Um-Bergström, Petra, et al.
Publicado: (2017)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

Increased cytotoxic T-cells in the airways of adults with former bronchopulmonary dysplasia
por: Um-Bergström, Petra, et al.
Publicado: (2022)

Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia
por: Alvira, Cristina M.
Publicado: (2016)

Home Immunization with Palivizumab-A Randomized Pilot Study Describing Safety Aspects and Parents’ Preferences
por: Ebersjö, Christina, et al.
Publicado: (2023)

Role of breast regression protein-39/YKL-40 in asthma and allergic responses
por: Lee, Chun Geun, et al.
Publicado: (2010)

Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
por: Wang, Jing, et al.
Publicado: (2018)

Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling
por: Lai, Tianwen, et al.
Publicado: (2016)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

High-resolution targeted bisulfite sequencing reveals blood cell type-specific DNA methylation patterns in IL13 and ORMDL3
por: Söderhäll, Cilla, et al.
Publicado: (2021)

YKL-40 is correlated with FEV(1) and the asthma control test (ACT) in asthmatic patients: influence of treatment
por: Lai, Tianwen, et al.
Publicado: (2015)

CHI3L1 polymorphisms, cord blood YKL-40 levels and later asthma development
por: Usemann, Jakob, et al.
Publicado: (2016)

Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations
por: Liu, Lei, et al.
Publicado: (2019)

Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia
por: Fang, Li-Ching, et al.
Publicado: (2023)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Biomarkers for the Phenotyping and Monitoring of Asthma in Children
por: James, Anna, et al.
Publicado: (2016)

Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia
por: Cohen, Jennifer, et al.
Publicado: (2007)

Early Life Wheeze and Risk Factors for Asthma—A Revisit at Age 7 in the GEWAC-Cohort
por: Holmdahl, Idun, et al.
Publicado: (2021)

The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives
por: Gorgisen, Gokhan, et al.
Publicado: (2022)

Risk of asthma in preterm infants with bronchopulmonary dysplasia: a systematic review and meta-analysis
por: Sun, Tong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7vadiqptfan0965ea37ahusdf9